Can V Call it a comeback for VC—yet

Two years into the market slowdown, VC dealmaking has remained surprisingly resilient. Deal counts have risen for three consecutive quarters, according to PitchBook estimates, and median valuation figures have risen too. On their own, these trends point to a return in market strength, but alongside the poor exit environment, it could be that even strong companies are finally being pushed to raise more capital. There's still plenty of time left in 2024 for GPs to see a reversal of their fortunes.

Total take-private deal value in North America and Europe topped $61 billion in Q2, a fourfold increase over the prior quarter. The period included Silver Lake's acquisition of Endeavor, the largest take-private in 10 years at $25 billion in enterprise value. Exit value in the US has tracked solidly, as many firms have secured deals through partial exits, continuation funds, and rolling minority stakes.

VC investors continue to play in the gaming space. Several high-profile firms from Andreessen Horowitz to Bitkraft Ventures have launched blockbuster gaming funds this year, lured by opportunities in augmented and virtual reality as well as a renewed interest in Web3 gaming.

With VC deals down across the US and Europe, it's no surprise that the Asia-Pacific region has also fallen well below 2021's highs. Healthcare VC deal value in the region has remained consistent, at $2.6 billion in the first quarter—with companies in the sector attracting 16.4% of VC investment

In today's market, PE funds race to adopt the latest technology to stay ahead. While many embrace digital solutions to streamline back-office functions, amidst AI's promise of game-changing results, leaders remain uncertain on which tools will give their teams the edge to win—from screening and diligence to successful exits. Leading firms such as CVC, Warburg Pincus, Riverside, and others have chosen Mosaic's advanced digital modeling platform to optimize their investment analysis. Mosaic delivers precise, data-driven insights, enabling teams to swiftly evaluate LBO opportunities and make informed decisions that maximize returns across the deal lifecycle. Mosaic's integration with AI empowers investors to bring static analysis to life, enhancing decision-making while seamlessly integrating into existing workflows.

Key Focus- Over the past two years, the pharma services market has emerged as the hottest area of healthcare for PE investment. The sector covers contract and outsourced services for the biopharmaceutical industry. The recent trend covers, four segments: outsourcing,

clinical services,

consulting services, and

manufacturing and distribution.

Three key trends have powered growth and investment in pharma services:

scientific advancements,

a growing emphasis on specialty drugs and

consolidation opportunities for outsourcing organizations.